Research Scientist Respiratory and Emerging Viruses

7 days left

Gilead Sciences, Inc.
Foster City, California
See job description.
Sep 14, 2021
Sep 25, 2021
Jobseeker Type
Organization Type
Full Time
Research Scientist Respiratory and Emerging Viruses
United States - California - Foster City

Gilead Sciences, Inc. is a research-based bio-pharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gileads therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions.

Making an impact on a global scale
Inclusion is one of the companys five core values. Thats because we know that we are stronger and more innovative at Gilead when we are informed by a diverse set of backgrounds, experiences and points of view. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide.

When you join Gilead, you join our mission to change the world by enabling people to live healthier and more fulfilling lives. Come join a mission-driven bio-pharmaceutical organization that values inclusion and diversity, has a strong portfolio of products, and is constantly #CreatingPossible


Specific Responsibilities:

Seeking a highly motivated, creative and collaborative individual with a strong motivation for and dedication to the discovery of new life-saving medicines. The candidate will join our internal efforts focused on the research and development of novel medicines for treatment and prevention of respiratory and emerging viruses. The successful candidate will work in a highly collaborative environment to support the discovery, optimization, and preclinical development of novel antiviral drug candidates. Primary responsibilities will include leading in vitro and in vivo virology studies to characterize newly discovered molecules as well as designing and evaluating new targets and therapeutic approaches in a fast-paced team environment. The successful candidate would be expected to:
  • Independently plan, design, implement and analyze laboratory experiments and studies to support the discovery of antiviral drugs, the development of drug candidates, and/or the research in support of marketed products, and to advance scientific knowledge of drug target and relevant biological processes
  • Design and develop efficient and reliable assays and tools for profiling drug candidate molecules
  • Conduct in-depth characterization of mechanisms of antiviral activity and resistance profiles
  • Function as a lead and/or core member of one or more multidisciplinary drug discovery teams
  • Interact closely with other parts and functions of the Gilead R&D organization including medicinal and structural chemistry, high through-put screening, biologics engineering, drug metabolism and safety, as well as clinical development and regulatory affairs.
  • Identify and support external collaborations, oversee external studies with academic collaborators and contract research organizations
  • Participate in the assessment of external business development opportunities.
  • Regularly present results and updates at project team meetings, project and portfolio reviews, and other internal meetings
  • Build and continue expanding the understanding and knowledge of research and development in the area of respiratory and emerging/neglected viruses
  • Represent Gilead at scientific meetings and through high impact scientific communications

Gilead is a fast-paced, data-driven, scientifically rigorous organization with inclusive culture and strong motivation to solve unmet medical needs and the role will suit a scientist who is able to thrive in this type of environment.

Knowledge, Experience and Skills:

PhD or equivalent degree in a relevant life science discipline (virology, infectious diseases, immunology, cellular or molecular biology)

Minimum of 4 years post-PhD experience focused on innovative research in virology with proven achievements in industrial settings, including peer-reviewed manuscripts.

Extensive understanding of and experience with principles and techniques in virology, molecular biology and cellular biology

Willingness to conduct experiments in BSL3 containment laboratory

Experience with independently designing, conducting, and analyzing critical experiments and studies. Strong ability to recognize and interpret patterns, trends and anomalies in datasets and results

Endorsement of teamwork and understanding of principles of cross-functional scientific collaboration

Strong professional motivation and desire to excel in a productive and fast-pace R&D organization with focus on clearly defined goals and objectives

Excellent interpersonal, written and verbal communication skills. Ability to communicate effectively within the Virology group and multidisciplinary groups within Research.

For jobs in the United States:

As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact for assistance.

Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Gilead has made the decision to require all U.S. employees and contractors to receive the COVID-19 vaccines as a condition of employment. Full vaccination is defined as two weeks after both doses of a two-dose vaccine or two weeks since a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation.\u200b

For more information about equal employment opportunity protections, please view the EEO is the Law' poster.



Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.

To apply, visit

Copyright 2021 Inc. All rights reserved.

Posted by the FREE value-added recruitment advertising agency


Similar jobs

Similar jobs